Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Outcomes of deprescribing for people with life-limiting conditions: A systematic review

Lookup NU author(s): Rajeev ShresthaORCiD, Dr Emily Shaw, Dr David SinclairORCiD, Dr Felicity DewhurstORCiD, Professor Adam ToddORCiD

Downloads

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Abstract

© The Author(s) 2026. This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Background: Polypharmacy and inappropriate medication are common amongst people with life-limiting conditions. Whilst deprescribing may help reduce these medication-related issues, supporting evidence in this population group is limited. Aim: To synthesise evidence on the outcomes of deprescribing in people with life-limiting conditions. Design: Systematic review. Data source: MEDLINE, Embase, Scopus, PsycINFO and CINAHL were searched. Original studies published between Jan 2000 and Dec 2024 in English were included. Result: A total of 17,457 hits were screened, of which 46 original studies met the inclusion criteria. Most eligible studies were pre-post interventional (n = 14) or cohort studies (n = 14), conducted primarily in nursing homes or long-term care facilities (n = 20) and hospitals (n = 16). The majority originated from North America (n = 20) and Australia (n = 7). A wide range of outcome variables were examined, with a primary focus on clinical outcomes. All studies assessing the impact on the number of medications used reported either a reduction in overall medication burden or inappropriate medications (n = 15), or no significant change (n = 3). Regarding mortality, most studies (10 studies) reported no impact, while 3 studies each reported increased and decreased mortality. For other outcomes, the majority of studies reported that deprescribing had no effect. Conclusion: This systematic review suggests that deprescribing offers some benefits, including reduced medication burden and costs in people with life-limiting conditions. While there is no strong evidence for harm, a small proportion of patients reported increased risks, so careful monitoring is essential. Further research should explore how deprescribing outcomes vary by disease condition and medication type.

Publication metadata

Author(s): Shrestha R, Shaw E, Mullen L, Sinclair D, Dewhurst F, Todd A

Publication type: Review

Publication status: Published

Journal: Palliative Medicine

Year: 2026

Pages: epub ahead of print

Online publication date: 22/02/2026

Acceptance date: 02/04/2018

ISSN (print): 0269-2163

ISSN (electronic): 1477-030X

Publisher: SAGE Publications Ltd

URL: https://doi.org/10.1177/02692163261416281

DOI: 10.1177/02692163261416281

Share